JPRN-UMIN000019953
Completed
N/A
The evaluation of airway and/or lung inflammation via a fraction of exhaled nitric oxide - The evaluation of airway and/or lung inflammation via a fraction of exhaled nitric oxide
agoya University0 sites780 target enrollmentNovember 27, 2015
Conditionsrespiratory disease
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- respiratory disease
- Sponsor
- agoya University
- Enrollment
- 780
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •patients with hemoptysis
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
N/A
Analysis of Airway Inflammatory state alteration after intravenous L-Arginine loadingChildren who are required growth hormone (GH) stimulation tests to diagnose GH deficiency. These are children whose heights are two standard deviations (SD) below the mean for age and sex, and/or whose growth velocities are 1.5 SD below the mean for age and sex over 2 years'follow-up, or whose pediatric endocrinologists order growth hormone (GH) stimulation test for another reasons.JPRN-UMIN000027260Osaka City University Graduate School of Medicine15
Recruiting
N/A
Evaluation of symptoms, respiratory, pulmonary image and inflammation in patients who have been hospitalized for coronavirus infection in the period of a year, multicentric study (fenix)RBR-8j9kqyFaculdade de Medicina de Botucatu
Not Yet Recruiting
N/A
ung function in post covidCTRI/2021/05/033518All India Institute of Medical Sciences
Recruiting
N/A
Analyses of lung, airways, and pleural lesions using probe-based confocal laser endomicroscopyPulmonary and pleural diseasesJPRN-UMIN000018518Fujita Health University60
Active, Not Recruiting
Phase 1
Aggravated airway inflammation: research on biological treatment (Mepolizumab) AirGOs-biologicsA triad of chronic rhinosinusitis with nasal polyps (CRSwNP), asthma and NSAID exacerbated respiratory disease (NERD)Therapeutic area: Diseases [C] - Ear, nose and throat diseases [C09]EUCTR2020-000421-76-FIHelsinki University Hospital120